• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Cipher Pharmaceuticals Inc

+ Add to Watchlist


6.029 EUR 0.0000.00%

As of 09:32:37 ET on 07/11/2014.

Snapshot for Cipher Pharmaceuticals Inc (PHE)

Open: - Day's Range: - Volume: 0
Previous Close: 6.029 52wk Range: 4.113 - 6.917 1-Yr Rtn: +47.88%

Stock Chart for PHE

No chart data available.
  • PHE:GR 6.029
  • 1D
  • 1M
  • 1Y
Interactive PHE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 13.4683
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) 0.6550
Est. PEG Ratio -
Market Cap (M EUR) 151.98
Shares Outstanding (M) 25.21
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHE

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for PHE

Cipher Pharmaceuticals Inc. is involved in the licensing, clinical development, and regulatory approval of prescription medications utilizing drug delivery technologies or new pharmaceuticals. The Company also conducts clinical trials, regulatory affairs services, and statistical analysis for the pharmaceutical, biotechnology, and medical devices industries.

Shawn Patrick O'BrienChief Executive OfficerNorman EvansCFO/Secretary
Joan ChypyhaVP:Marketing & SalesJason D GrossVP:Scientific Affairs
More Company Profile & Key Executives for PHE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil